VitalHub has a 64 per cent upside, says Paradigm

Record quarterly results are the right prescription for health services software company VitalHub, according to Paradigm Capital analyst Daniel Rosenberg, who reiterated a “Buy” rating in a Monday report.

Related Keywords

United Kingdom ,Daniel Rosenberg ,Dan Matlow ,Coyote Software ,Vitalhub Stock Quote ,Paradigm Capital ,Professional Services ,